Could Opioids Affect Cancer Recurrence or Metastases? Current Experimental and Translational Evidence

Morphine and Metastasis

Volumn , Issue , 2013, Pages 79-94

  Shanahan, Hilary ^a   Buggy, Donal ^b   Parat, Marie Odile ^c  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Anaesthesia; Analgesia; Cancer recurrence; Metastases; Morphine; Opioids; Pain

Indexed keywords

EID: 84956550291     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-94-007-5678-6_6     Document Type: Chapter

References (61)

1. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ (2008) Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109:180-187
2. Chen C, Farooqui M, Gupta K (2006) Morphine stimulates vascular endothelial growth factor-like signaling in mouse retinal endothelial cells. Curr Neurovasc Res 3:171-180
3. Cummings KC III, Xu F, Cummings LC, Cooper GS (2012) A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology 116:797-806
4. Day A, Smith R, Jourdan I, Fawcett W, Scott M, Rockall T (2012) Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. Br J Anaesth 109:185-190
5. De Oliveira G Jr, Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ (2011) Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med 36:271-277
6. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ (2009) Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth 103:685-690
7. Deegan CA, Murray D, Doran P, Moriarty DC, Sessler DI, Mascha E, Kavanagh BP, Buggy DJ (2010) Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med 35:490-495
8. Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG, Buggy DJ (2011) Direct effect of morphine on breast cancer cell function in vitro: role of the NET1 gene. Br J Anaesth 107:916-923
9. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI (2006) Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology 105:660-664
10. Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523-1531
11. Fichna J, Krajewska U, Rozalski M, Mirowski M, Janecka A (2005) Characterization of the [125I] endomorphin-2 binding sites in the MCF7 breast cancer cell line. Peptides 26:295-299
12. Forget P, Collet V, Lavand’homme P, De Kock M (2010a) Does analgesia and condition influence immunity after surgery? Effects of fentanyl, ketamine and clonidine on natural killer activity at different ages. Eur J Anaesthesiol 27:233-240
13. Forget P, Vandenhende J, Berliere M, Machiels JP, Nussbaum B, Legrand C, De Kock M (2010b) Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg 110:1630-1635
14. Forget P, Tombal B, Scholtes JL, Nzimbala J, Meulders C, Legrand C, Van Cangh P, Cosyns JP, De Kock M (2011) Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 28:830-835
15. Franchi S, Panerai AE, Sacerdote P (2007) Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment. Brain Behav Immun 21:767-774
16. Fuggetta MP, Di Francesco P, Falchetti R, Cottarelli A, Rossi L, Tricarico M, Lanzilli G (2005) Effect of morphine on cell-mediated immune responses of human lymphocytes against allogeneic malignant cells. J Exp Clin Cancer Res 24:255-263
17. Fujioka N, Nguyen J, Chen C, Li Y, Pasrija T, Niehans G, Johnson KN, Gupta V, Kratzke RA, Gupta K (2011) Morphine-induced epidermal growth factor pathway activation in non small cell lung cancer. Anesth Analg 113:1353-1364
18. Gach K, Szemraj J, Fichna J, Piestrzeniewicz M, Delbro DS, Janecka A (2009) The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line. Chem Biol Drug Des 74:390-396
19. Gach K, Szemraj J, Wyrebska A, Janecka A (2011) The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line. Mol Biol Rep 38:1231-1236
20. Gaspani L, Bianchi M, Limiroli E, Panerai AE, Sacerdote P (2002) The analgesic drug tramadol prevents the effect of surgery on natural killer cell activity and metastatic colonization in rats. J Neuroimmunol 129:18-24
21. Gupta K, Kshirsagar S, Chang L, Schwartz R, Law PY, Yee D, Hebbel RP (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth. Cancer Res 62:4491-4498
22. Harimaya Y, Koizumi K, Andoh T, Nojima H, Kuraishi Y, Saiki I (2002) Potential ability of morphine to inhibit the adhesion, invasion and metastasis of metastatic colon 26-L5 carcinoma cells. Cancer Lett 187:121-127
23. Hatsukari I, Hitosugi N, Ohno R, Hashimoto K, Nakamura S, Satoh K, Nagasaka H, Matsumoto I, Sakagami H (2007) Induction of apoptosis by morphine in human tumor cell lines in vitro. Anticancer Res 27:857-864
24. Hatzoglou A, Ouafik L, Bakogeorgou E, Thermos K, Castanas E (1995) Morphine cross-reacts with somatostatin receptor SSTR2 in the T47D human breast cancer cell line and decreases cell growth. Cancer Res 55:5632-5636
25. Hatzoglou A, Bakogeorgou E, Castanas E (1996) The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol 296:199-207
26. Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S (2010) Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study. Br J Anaesth 105:145-149
27. Kampa M, Bakogeorgou E, Hatzoglou A, Damianaki A, Martin PM, Castanas E (1997) Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors. Eur J Pharmacol 335:255-265
28. Kerros C, Cavey T, Sola B, Jauzac P, Allouche S (2009) Somatostatin and opioid receptors do not regulate proliferation or apoptosis of the human multiple myeloma U266 cells. J Exp Clin Cancer Res 28:77
29. Koodie L, Ramakrishnan S, Roy S (2010) Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol 177:984-997
30. Lennon FE, Mirzapoiazova T, Mambetsariev B, Salgia R, Moss J, Singleton PA (2012) Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 116:857-867
31. Leo S, Nuydens R, Meert TF (2009) Opioid-induced proliferation of vascular endothelial cells. J Pain Res 2:59-66
32. Lin X, Li Q, Wang YJ, Ju YW, Chi ZQ, Wang MW, Liu JG (2007) Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J 406:215-221
33. Lin X, Wang YJ, Li Q, Hou YY, Hong MH, Cao YL, Chi ZQ, Liu JG (2009) Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway. FEBS J 276:2022-2036
34. Looney M, Doran P, Buggy DJ (2010) Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor beta in women undergoing anesthesia and surgery for breast cancer. Anesthesiology 113:1118-1125
35. Lucchinetti E, Awad AE, Rahman M, Feng J, Lou PH, Zhang L, Ionescu L, Lemieux H, Thebaud B, Zaugg M (2012) Antiproliferative effects of local anesthetics on mesenchymal stem cells: potential implications for tumor spreading and wound healing. Anesthesiology 116:841-856
36. Luk K, Boatman S, Johnson KN, Dudek OA, Ristau N, Vang D, Nguyen J, Gupta K (2012) Influence of morphine on pericyte-endothelial interaction: implications for antiangiogenic therapy. J Oncol 2012:458-385
37. Macfarlane GJ, McBeth J, Silman AJ (2001) Widespread body pain and mortality: prospective population based study. BMJ 323:662-665
38. Maneckjee R, Minna JD (1990) Opioid and nicotine receptors affect growth regulation of human lung cancer cell lines. Proc Natl Acad Sci USA 87:3294-3298
39. Maneckjee R, Minna JD (1994) Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ 5:1033-1040
40. Maneckjee R, Biswas R, Vonderhaar BK (1990) Binding of opioids to human MCF-7 breast cancer cells and their effects on growth. Cancer Res 50:2234-2238
41. Martucci C, Panerai AE, Sacerdote P (2004) Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses. Pain 110:385-392
42. Mathew B, Lennon FE, Siegler J, Mirzapoiazova T, Mambetsariev N, Sammani S, Gerhold LM, LaRiviere PJ, Chen CT, Garcia JGN, Salgia R, Moss J, Singleton PA (2011) The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation. Anesth Analg 112:558-567
43. Mojadadi S, Jamali A, Khansarinejad B, Soleimanjahi H, Bamdad T (2009) Acute morphine administration reduces cell-mediated immunity and induces reactivation of latent herpes simplex virus type 1 in BALB/c mice. Cell Mol Immunol 6:111-116
44. Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI (2011) Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: randomised trial. BMJ 342:d1491
45. Nylund G, Pettersson A, Bengtsson C, Khorram-Manesh A, Nordgren S, Delbro DS (2008) Functional expression of mu-opioid receptors in the human colon cancer cell line, HT-29, and their localization in human colon. Dig Dis Sci 53:461-466
46. Ohara T, Itoh T, Takahashi M (2005) Immunosuppression by morphine-induced lymphocyte apoptosis: is it a real issue? Anesth Analg 101:1117-1122
47. Qin Y, Chen J, Li L, Liao CJ, Liang YB, Guan EJ, Xie YB (2012) Exogenous morphine inhibits human gastric cancer MGC-803 cell growth by cell cycle arrest and apoptosis induction. Asian Pac J Cancer Prev 13:1377-1382
48. Sasamura T, Nakamura S, Iida Y, Fujii H, Murata J, Saiki I, Nojima H, Kuraishi Y (2002) Morphine analgesia suppresses tumor growth and metastasis in a mouse model of cancer pain produced by orthotopic tumor inoculation. Eur J Pharmacol 441:185-191
49. Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B (2004) Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats: dose and timing study. Neuroimmunomodulation 11:255-260
50. Singleton PA, Lingen MW, Fekete MJ, Garcia JGN, Moss J (2006) Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: role of receptor transactivation. Microvasc Res 72:3-11
51. Smith TJ, Staats PS, Deer T, Stearns LJ, Rauck RL, Boortz-Marx RL, Buchser E, Catala E, Bryce DA, Coyne PJ, Pool GE (2002) Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity, and survival. J Clin Oncol 20:4040-4049
52. Sueoka N, Sueoka E, Okabe S, Fujiki H (1996) Anti-cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression. Carcinogenesis 17:2337-2341
53. Sueoka E, Sueoka N, Kai Y, Okabe S, Suganuma M, Kanematsu K, Yamamoto T, Fujiki H (1998) Anticancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun 252:566-570
54. Tegeder I, Grosch S, Schmidtko A, Haussler A, Schmidt H, Niederberger E, Scholich K, Geisslinger G (2003) G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 63:1846-1852
55. Tsui BC, Rashiq S, Schopflocher D, Murtha A, Broemling S, Pillay J, Finucane BT (2010) Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anaesth 57:107-112
56. Ustun F, Durmus-Altun G, Altaner S, Tuncbilek N, Uzal C, Berkarda S (2011) Evaluation of morphine effect on tumour angiogenesis in mouse breast tumour model, EATC. Med Oncol 28:1264-1272
57. Varadhan KK, Neal KR, Dejong CHC, Fearon KCH, Ljungqvist O, Lobo DN (2010) The enhanced recovery after surgery (ERAS) pathway for patients undergoing major elective open colorectal surgery: a meta-analysis of randomized controlled trials. Clin Nutr 29:434-440
58. Wuethrich PY, Hsu Schmitz SF, Kessler TM, Thalmann GN, Studer UE, Stueber F, Burkhard FC (2010) Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology 113:570-576
59. Yin D, Woodruff M, Zhang Y, Whaley S, Miao J, Ferslew K, Zhao J, Stuart C (2006) Morphine promotes Jurkat cell apoptosis through pro-apoptotic FADD/P53 and anti-apoptotic PI3K/Akt/NF-kappaB pathways. J Neuroimmunol 174:101-107
60. Zagon IS, McLaughlin PJ (2003) Opioids and the apoptotic pathway in human cancer cells. Neuropeptides 37:79-88
61. Zagon IS, Rahn KA, McLaughlin PJ (2007) Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells. Neuropeptides 41:441-452